Germany: Wallaby accelerating global expansion plans with phenox

Michael Alper, founder and CEO Wallaby Medical

Wallaby Medical, a medical technology company focused on developing and commercializing neurovascular interventional products for treating stroke, has acquired phenox, including phenox’s femtos, a German-based technology company focused on the neurovascular space, for a total consideration of approximately €500m (US$536m) including milestone payments. The acquisition is one of the largest cross-border transactions in the medical…

You must be a HMI Subscriber to view this content.

Subscribe Now »